Haller, I.-E.; Reinwald, M.; Kah, J.; Eggert, F.A.M.; Schwarzlose-Schwarck, S.; Jahnke, K.; Lüth, S.; Dammermann, W.
Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays. Antibodies 2025, 14, 27.
https://doi.org/10.3390/antib14020027
AMA Style
Haller I-E, Reinwald M, Kah J, Eggert FAM, Schwarzlose-Schwarck S, Jahnke K, Lüth S, Dammermann W.
Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays. Antibodies. 2025; 14(2):27.
https://doi.org/10.3390/antib14020027
Chicago/Turabian Style
Haller, Isabel-Elena, Mark Reinwald, Janine Kah, Franz A. M. Eggert, Sandra Schwarzlose-Schwarck, Kristoph Jahnke, Stefan Lüth, and Werner Dammermann.
2025. "Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays" Antibodies 14, no. 2: 27.
https://doi.org/10.3390/antib14020027
APA Style
Haller, I.-E., Reinwald, M., Kah, J., Eggert, F. A. M., Schwarzlose-Schwarck, S., Jahnke, K., Lüth, S., & Dammermann, W.
(2025). Low Serological Agreement of Hepatitis E in Immunocompromised Cancer Patients: A Comparative Study of Three Anti-HEV Assays. Antibodies, 14(2), 27.
https://doi.org/10.3390/antib14020027
